| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/20/2004 | EP1469071A1 Method of screening drug for improving insulin resistance |
| 10/20/2004 | EP1468999A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 10/20/2004 | EP1468990A1 Piperazine derivative |
| 10/20/2004 | EP1468694A1 Remedies for anorexia or lifestyle-related diseases and method of screening the same |
| 10/20/2004 | EP1468693A2 Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus |
| 10/20/2004 | EP1468692A2 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma |
| 10/20/2004 | EP1468682A1 Therapeutic combinations comprising amlodipine and atorvastatin |
| 10/20/2004 | EP1468681A1 Fenofibrate pharmaceutical composition with a higher bioavailability and its manufacturing process |
| 10/20/2004 | EP1468614A1 Method of improving the growth or the efficiency of feed conversion of an animal and composition for use therein |
| 10/20/2004 | EP1468092A2 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 10/20/2004 | EP1468091A2 Transmembrane protein |
| 10/20/2004 | EP1468078A1 Method and device for identifying substances capable of modulating adipocyte differentiation |
| 10/20/2004 | EP1468020A2 Multimers of receptor-binding ligands |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1468017A1 A complex of a human foxc2 protein and a foxc2-interacting protein |
| 10/20/2004 | EP1467998A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 10/20/2004 | EP1467996A1 Pyrimidotriazines as phosphatase inhibitors |
| 10/20/2004 | EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/20/2004 | EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof |
| 10/20/2004 | EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION |
| 10/20/2004 | EP1467978A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467972A1 Indazole compounds useful as protein kinase inhibitors |
| 10/20/2004 | EP1467964A1 Polymorphic forms of nateglinide |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 10/20/2004 | EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 10/20/2004 | EP1467739A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 10/20/2004 | EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 10/20/2004 | EP1467730A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 10/20/2004 | EP1467728A1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1307264B1 New pharmaceutical composition |
| 10/20/2004 | EP1289936B1 Substituted stilbenes as glucose uptake enhancers |
| 10/20/2004 | EP1282611B1 Substituted phenylacetamides and their use as glucokinase activators |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1261588B1 IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS |
| 10/20/2004 | EP1246619B1 Urotensin-ii receptor antagonists |
| 10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
| 10/20/2004 | EP1217902B1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 10/20/2004 | EP1204660B1 Serotonergic benzothiophenes |
| 10/20/2004 | EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors |
| 10/20/2004 | EP1117416B1 Plant extracts for the treatment of increased bone resorption |
| 10/20/2004 | EP0886528B1 Use of coxiella bacteria to treat autoimmune disease |
| 10/20/2004 | CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease |
| 10/20/2004 | CN1538958A Solvates of lercanidipine hydro chloride and new crystalline forms of lercanidipine hydrochloride |
| 10/20/2004 | CN1538956A Spiro compounds |
| 10/20/2004 | CN1538843A Neurotrophic tacrolimus analogs |
| 10/20/2004 | CN1538839A Swine growth promoters and method of promoting swine growth |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1538812A Body temp-raising agent of amino acidds for eating or drinking and for medical use |
| 10/20/2004 | CN1538811A Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase intramyocellular lipid level |
| 10/20/2004 | CN1538809A Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, used thereof and methods of making same |
| 10/20/2004 | CN1537946A Method of extracting dietary fiber from sogbean drges and chewing tablet |
| 10/20/2004 | CN1537863A Herminium's triochistisaponine extract and its extraction refining method and its medical use |
| 10/20/2004 | CN1537634A Medicine contg. biotin for treating diabetes |
| 10/20/2004 | CN1537629A Quickly dissolving amaranth seed powder for lower sugar content (in blood or urine) |
| 10/20/2004 | CN1537602A Traditional Chinese medicine pill for taking care of heart, brain and kidney |
| 10/20/2004 | CN1537601A Health-care food for diabetes mellitus patient |
| 10/20/2004 | CN1537584A Weight-reducing granule and its prepn. method |
| 10/20/2004 | CN1537583A Weight-reducing tablet and its prepn. method |
| 10/20/2004 | CN1537562A Compound flavone capsule and pellet prepn. method |
| 10/20/2004 | CN1537545A Sugar-free type blood-fat-lowering granule, and its prepn. method |
| 10/20/2004 | CN1537544A Composition of medicine for lowering fat, and its prepn. method |
| 10/20/2004 | CN1537531A Celecoxib compositions |
| 10/20/2004 | CN1171902C Antisercretory factor petides regulating pathological permeability changes |
| 10/20/2004 | CN1171900C Novel, ubiquitous potassium-channel proteins and genes for the same |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171888C Substituted purin derivatives, preparation method and use |
| 10/20/2004 | CN1171872C Compounds for modulation of PPAP gamma activity |
| 10/20/2004 | CN1171615C Chinese medicine prepn for treating fatty liver and obesity and its preparation method |
| 10/20/2004 | CN1171594C Composition containing pearl powder and ascorbic acid |
| 10/19/2004 | USRE38629 Bioavailability; non-insulin depedent diabetes; hypoglycemic agents; treating metabolic disorders, impaired glucose tolerance, and insulin resistance |
| 10/19/2004 | US6806312 Thermoplastic resin composition |
| 10/19/2004 | US6806280 Polymorph of 5-[4-[2-(n-methyl-n(2-pyridyl)amino)ethoxy]benzyl]-thiazolidine-2,4-dione, maleic acid salt |
| 10/19/2004 | US6806274 Quinazoline derivatives |
| 10/19/2004 | US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 10/19/2004 | US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent |
| 10/19/2004 | US6806252 Synergistic mixture of casein polypeptide to promote calcium absorption and genistein which inhibits bone resorption and promotes osteogenesis; prevent decrease in bone density and onset of osteoporosis |
| 10/19/2004 | US6805873 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment |
| 10/15/2004 | CA2464501A1 Treatment of lipodystrophy (lipid redistribution syndrome) |
| 10/14/2004 | WO2004087938A1 Novel physiologically active substances pf1270a, b and c |
| 10/14/2004 | WO2004087880A2 Compounds and their use to treat diabetes and related disorders |
| 10/14/2004 | WO2004087763A1 Modified antibody against cd22 and utilization thereof |
| 10/14/2004 | WO2004087727A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 10/14/2004 | WO2004087680A1 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 10/14/2004 | WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 10/14/2004 | WO2004087657A1 Anti-obesity agent |
| 10/14/2004 | WO2004087655A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter |
| 10/14/2004 | WO2004087641A1 Hydrazone derivative |
| 10/14/2004 | WO2004087206A2 Methods of treating diabetes by blocking vegf-mediated activity |
| 10/14/2004 | WO2004087199A1 Composition for improving insulin resistance |
| 10/14/2004 | WO2004087194A2 Use of a dg931 protein for treating diabetes, obesity and metabolic syndrome |
| 10/14/2004 | WO2004087173A2 Formulations for mediating inflammation and for reducing blood cholesterol |
| 10/14/2004 | WO2004087159A1 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 10/14/2004 | WO2004086881A1 A process for preparation of hypoglycemic foods and formulations thereof |
| 10/14/2004 | WO2004086878A2 Improved dietary fiber containing materials comprising low molecular weight glucan |
| 10/14/2004 | WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages) |